nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—CYP2D6—Niacin—atherosclerosis	0.0921	0.149	CbGbCtD
Amsacrine—ABCB1—Ezetimibe—atherosclerosis	0.0832	0.134	CbGbCtD
Amsacrine—ABCB1—Simvastatin—atherosclerosis	0.0773	0.125	CbGbCtD
Amsacrine—ABCB1—Pravastatin—atherosclerosis	0.0756	0.122	CbGbCtD
Amsacrine—ABCB1—Lovastatin—atherosclerosis	0.0756	0.122	CbGbCtD
Amsacrine—CYP2D6—Simvastatin—atherosclerosis	0.0728	0.118	CbGbCtD
Amsacrine—CYP2D6—Pravastatin—atherosclerosis	0.0713	0.115	CbGbCtD
Amsacrine—CYP2D6—Lovastatin—atherosclerosis	0.0713	0.115	CbGbCtD
Amsacrine—Proteinuria—Rosuvastatin—atherosclerosis	0.0034	0.0147	CcSEcCtD
Amsacrine—Protein urine present—Rosuvastatin—atherosclerosis	0.00336	0.0145	CcSEcCtD
Amsacrine—Hepatotoxicity—Niacin—atherosclerosis	0.00282	0.0122	CcSEcCtD
Amsacrine—Necrosis—Niacin—atherosclerosis	0.00277	0.012	CcSEcCtD
Amsacrine—Proteinuria—Simvastatin—atherosclerosis	0.0027	0.0116	CcSEcCtD
Amsacrine—Protein urine present—Simvastatin—atherosclerosis	0.00266	0.0115	CcSEcCtD
Amsacrine—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00256	0.0111	CcSEcCtD
Amsacrine—Inflammation—Ezetimibe—atherosclerosis	0.00256	0.0111	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00253	0.0109	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00249	0.0107	CcSEcCtD
Amsacrine—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00248	0.343	CbGdCrCtD
Amsacrine—Inflammation—Simvastatin—atherosclerosis	0.00244	0.0105	CcSEcCtD
Amsacrine—Hepatic failure—Rosuvastatin—atherosclerosis	0.00241	0.0104	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00237	0.0102	CcSEcCtD
Amsacrine—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00237	0.328	CbGdCrCtD
Amsacrine—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00237	0.328	CbGdCrCtD
Amsacrine—Hyperuricaemia—Niacin—atherosclerosis	0.00235	0.0101	CcSEcCtD
Amsacrine—Blood uric acid increased—Niacin—atherosclerosis	0.00222	0.00956	CcSEcCtD
Amsacrine—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00217	0.00935	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00214	0.00924	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00211	0.00912	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00207	0.00895	CcSEcCtD
Amsacrine—Vascular purpura—Lovastatin—atherosclerosis	0.00206	0.00887	CcSEcCtD
Amsacrine—Hepatic failure—Lovastatin—atherosclerosis	0.00205	0.00883	CcSEcCtD
Amsacrine—Hepatic failure—Ezetimibe—atherosclerosis	0.00201	0.00866	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00198	0.00853	CcSEcCtD
Amsacrine—Vascular purpura—Simvastatin—atherosclerosis	0.00192	0.0083	CcSEcCtD
Amsacrine—Hepatic failure—Simvastatin—atherosclerosis	0.00191	0.00826	CcSEcCtD
Amsacrine—Purpura—Lovastatin—atherosclerosis	0.00191	0.00823	CcSEcCtD
Amsacrine—Atrial fibrillation—Simvastatin—atherosclerosis	0.00182	0.00783	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00179	0.00771	CcSEcCtD
Amsacrine—Purpura—Simvastatin—atherosclerosis	0.00178	0.0077	CcSEcCtD
Amsacrine—Vascular purpura—Pravastatin—atherosclerosis	0.00174	0.0075	CcSEcCtD
Amsacrine—Hepatic failure—Pravastatin—atherosclerosis	0.00173	0.00747	CcSEcCtD
Amsacrine—Atrial fibrillation—Niacin—atherosclerosis	0.00167	0.00719	CcSEcCtD
Amsacrine—Jaundice—Rosuvastatin—atherosclerosis	0.00163	0.00703	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00162	0.00701	CcSEcCtD
Amsacrine—Purpura—Pravastatin—atherosclerosis	0.00161	0.00696	CcSEcCtD
Amsacrine—Haematuria—Rosuvastatin—atherosclerosis	0.00159	0.00688	CcSEcCtD
Amsacrine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00158	0.00682	CcSEcCtD
Amsacrine—Affect lability—Pravastatin—atherosclerosis	0.00153	0.0066	CcSEcCtD
Amsacrine—Hepatitis—Rosuvastatin—atherosclerosis	0.0015	0.00648	CcSEcCtD
Amsacrine—Mood swings—Pravastatin—atherosclerosis	0.00147	0.00636	CcSEcCtD
Amsacrine—Infestation NOS—Ezetimibe—atherosclerosis	0.00139	0.006	CcSEcCtD
Amsacrine—Infestation—Ezetimibe—atherosclerosis	0.00139	0.006	CcSEcCtD
Amsacrine—Dysphagia—Niacin—atherosclerosis	0.00137	0.00589	CcSEcCtD
Amsacrine—Jaundice—Ezetimibe—atherosclerosis	0.00135	0.00585	CcSEcCtD
Amsacrine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00134	0.00579	CcSEcCtD
Amsacrine—Mental disorder—Rosuvastatin—atherosclerosis	0.00132	0.00567	CcSEcCtD
Amsacrine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00131	0.00567	CcSEcCtD
Amsacrine—Jaundice—Simvastatin—atherosclerosis	0.00129	0.00557	CcSEcCtD
Amsacrine—Hepatitis—Lovastatin—atherosclerosis	0.00127	0.00549	CcSEcCtD
Amsacrine—Hepatitis—Ezetimibe—atherosclerosis	0.00125	0.00538	CcSEcCtD
Amsacrine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00123	0.00529	CcSEcCtD
Amsacrine—Weight increased—Pravastatin—atherosclerosis	0.00122	0.00528	CcSEcCtD
Amsacrine—Weight decreased—Pravastatin—atherosclerosis	0.00122	0.00525	CcSEcCtD
Amsacrine—Hepatitis—Simvastatin—atherosclerosis	0.00119	0.00513	CcSEcCtD
Amsacrine—Stomatitis—Niacin—atherosclerosis	0.00119	0.00512	CcSEcCtD
Amsacrine—Jaundice—Niacin—atherosclerosis	0.00119	0.00512	CcSEcCtD
Amsacrine—Jaundice—Pravastatin—atherosclerosis	0.00117	0.00504	CcSEcCtD
Amsacrine—Angiopathy—Ezetimibe—atherosclerosis	0.00113	0.00488	CcSEcCtD
Amsacrine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00112	0.00485	CcSEcCtD
Amsacrine—Alopecia—Lovastatin—atherosclerosis	0.00112	0.00485	CcSEcCtD
Amsacrine—Alopecia—Ezetimibe—atherosclerosis	0.0011	0.00476	CcSEcCtD
Amsacrine—Haemoglobin—Niacin—atherosclerosis	0.0011	0.00474	CcSEcCtD
Amsacrine—Mental disorder—Ezetimibe—atherosclerosis	0.00109	0.00472	CcSEcCtD
Amsacrine—Haemorrhage—Niacin—atherosclerosis	0.00109	0.00471	CcSEcCtD
Amsacrine—Hepatitis—Niacin—atherosclerosis	0.00109	0.00471	CcSEcCtD
Amsacrine—Hypoaesthesia—Niacin—atherosclerosis	0.00109	0.00469	CcSEcCtD
Amsacrine—Malnutrition—Ezetimibe—atherosclerosis	0.00109	0.00469	CcSEcCtD
Amsacrine—Hepatitis—Pravastatin—atherosclerosis	0.00108	0.00464	CcSEcCtD
Amsacrine—Confusional state—Rosuvastatin—atherosclerosis	0.00108	0.00464	CcSEcCtD
Amsacrine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00107	0.00462	CcSEcCtD
Amsacrine—Infection—Rosuvastatin—atherosclerosis	0.00106	0.00457	CcSEcCtD
Amsacrine—Alopecia—Simvastatin—atherosclerosis	0.00105	0.00454	CcSEcCtD
Amsacrine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00104	0.0045	CcSEcCtD
Amsacrine—Vision blurred—Lovastatin—atherosclerosis	0.00104	0.0045	CcSEcCtD
Amsacrine—Mental disorder—Simvastatin—atherosclerosis	0.00104	0.0045	CcSEcCtD
Amsacrine—Anaemia—Ezetimibe—atherosclerosis	0.001	0.00433	CcSEcCtD
Amsacrine—Cardiac disorder—Pravastatin—atherosclerosis	0.000998	0.00431	CcSEcCtD
Amsacrine—Angiopathy—Niacin—atherosclerosis	0.000991	0.00428	CcSEcCtD
Amsacrine—Leukopenia—Lovastatin—atherosclerosis	0.000991	0.00428	CcSEcCtD
Amsacrine—Vision blurred—Simvastatin—atherosclerosis	0.000976	0.00421	CcSEcCtD
Amsacrine—Arrhythmia—Niacin—atherosclerosis	0.000976	0.00421	CcSEcCtD
Amsacrine—Alopecia—Niacin—atherosclerosis	0.000966	0.00417	CcSEcCtD
Amsacrine—Arrhythmia—Pravastatin—atherosclerosis	0.000961	0.00415	CcSEcCtD
Amsacrine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000958	0.00413	CcSEcCtD
Amsacrine—Anaemia—Simvastatin—atherosclerosis	0.000957	0.00413	CcSEcCtD
Amsacrine—Malnutrition—Niacin—atherosclerosis	0.000951	0.0041	CcSEcCtD
Amsacrine—Alopecia—Pravastatin—atherosclerosis	0.000951	0.0041	CcSEcCtD
Amsacrine—Leukopenia—Simvastatin—atherosclerosis	0.000927	0.004	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000918	0.00396	CcSEcCtD
Amsacrine—Pain—Rosuvastatin—atherosclerosis	0.000912	0.00393	CcSEcCtD
Amsacrine—Confusional state—Lovastatin—atherosclerosis	0.000911	0.00393	CcSEcCtD
Amsacrine—Infection—Lovastatin—atherosclerosis	0.000898	0.00387	CcSEcCtD
Amsacrine—Vision blurred—Niacin—atherosclerosis	0.000896	0.00387	CcSEcCtD
Amsacrine—Confusional state—Ezetimibe—atherosclerosis	0.000894	0.00386	CcSEcCtD
Amsacrine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000885	0.00382	CcSEcCtD
Amsacrine—Vision blurred—Pravastatin—atherosclerosis	0.000883	0.00381	CcSEcCtD
Amsacrine—Infection—Ezetimibe—atherosclerosis	0.000881	0.0038	CcSEcCtD
Amsacrine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000879	0.00379	CcSEcCtD
Amsacrine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000872	0.00376	CcSEcCtD
Amsacrine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000868	0.00374	CcSEcCtD
Amsacrine—Anaemia—Pravastatin—atherosclerosis	0.000866	0.00373	CcSEcCtD
Amsacrine—Anorexia—Lovastatin—atherosclerosis	0.000862	0.00372	CcSEcCtD
Amsacrine—Skin disorder—Ezetimibe—atherosclerosis	0.000861	0.00371	CcSEcCtD
Amsacrine—Confusional state—Simvastatin—atherosclerosis	0.000852	0.00368	CcSEcCtD
Amsacrine—Leukopenia—Niacin—atherosclerosis	0.000851	0.00367	CcSEcCtD
Amsacrine—Urticaria—Rosuvastatin—atherosclerosis	0.000847	0.00366	CcSEcCtD
Amsacrine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000843	0.00364	CcSEcCtD
Amsacrine—Infection—Simvastatin—atherosclerosis	0.00084	0.00362	CcSEcCtD
Amsacrine—Leukopenia—Pravastatin—atherosclerosis	0.000838	0.00362	CcSEcCtD
Amsacrine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000828	0.00357	CcSEcCtD
Amsacrine—Paraesthesia—Lovastatin—atherosclerosis	0.000812	0.0035	CcSEcCtD
Amsacrine—Anorexia—Simvastatin—atherosclerosis	0.000806	0.00348	CcSEcCtD
Amsacrine—Dyspnoea—Lovastatin—atherosclerosis	0.000806	0.00348	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000804	0.00347	CcSEcCtD
Amsacrine—Paraesthesia—Ezetimibe—atherosclerosis	0.000796	0.00343	CcSEcCtD
Amsacrine—Dyspnoea—Ezetimibe—atherosclerosis	0.00079	0.00341	CcSEcCtD
Amsacrine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000786	0.00339	CcSEcCtD
Amsacrine—Decreased appetite—Lovastatin—atherosclerosis	0.000786	0.00339	CcSEcCtD
Amsacrine—Fatigue—Lovastatin—atherosclerosis	0.000779	0.00336	CcSEcCtD
Amsacrine—Pain—Lovastatin—atherosclerosis	0.000773	0.00333	CcSEcCtD
Amsacrine—Confusional state—Pravastatin—atherosclerosis	0.000771	0.00332	CcSEcCtD
Amsacrine—Decreased appetite—Ezetimibe—atherosclerosis	0.000771	0.00332	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000765	0.0033	CcSEcCtD
Amsacrine—Asthenia—Rosuvastatin—atherosclerosis	0.000765	0.0033	CcSEcCtD
Amsacrine—Fatigue—Ezetimibe—atherosclerosis	0.000764	0.0033	CcSEcCtD
Amsacrine—Infection—Pravastatin—atherosclerosis	0.000759	0.00328	CcSEcCtD
Amsacrine—Paraesthesia—Simvastatin—atherosclerosis	0.000759	0.00327	CcSEcCtD
Amsacrine—Pain—Ezetimibe—atherosclerosis	0.000758	0.00327	CcSEcCtD
Amsacrine—Tachycardia—Niacin—atherosclerosis	0.000758	0.00327	CcSEcCtD
Amsacrine—Skin disorder—Niacin—atherosclerosis	0.000754	0.00325	CcSEcCtD
Amsacrine—Dyspnoea—Simvastatin—atherosclerosis	0.000754	0.00325	CcSEcCtD
Amsacrine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000748	0.00323	CcSEcCtD
Amsacrine—Feeling abnormal—Lovastatin—atherosclerosis	0.000745	0.00321	CcSEcCtD
Amsacrine—Anorexia—Niacin—atherosclerosis	0.00074	0.00319	CcSEcCtD
Amsacrine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000739	0.00319	CcSEcCtD
Amsacrine—Decreased appetite—Simvastatin—atherosclerosis	0.000735	0.00317	CcSEcCtD
Amsacrine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000731	0.00315	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00073	0.00315	CcSEcCtD
Amsacrine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00073	0.00315	CcSEcCtD
Amsacrine—Fatigue—Simvastatin—atherosclerosis	0.000729	0.00314	CcSEcCtD
Amsacrine—Anorexia—Pravastatin—atherosclerosis	0.000729	0.00314	CcSEcCtD
Amsacrine—Hypotension—Niacin—atherosclerosis	0.000725	0.00313	CcSEcCtD
Amsacrine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000725	0.00313	CcSEcCtD
Amsacrine—Pain—Simvastatin—atherosclerosis	0.000723	0.00312	CcSEcCtD
Amsacrine—Urticaria—Lovastatin—atherosclerosis	0.000718	0.0031	CcSEcCtD
Amsacrine—Abdominal pain—Lovastatin—atherosclerosis	0.000715	0.00308	CcSEcCtD
Amsacrine—Body temperature increased—Lovastatin—atherosclerosis	0.000715	0.00308	CcSEcCtD
Amsacrine—Dizziness—Rosuvastatin—atherosclerosis	0.000705	0.00304	CcSEcCtD
Amsacrine—Urticaria—Ezetimibe—atherosclerosis	0.000704	0.00304	CcSEcCtD
Amsacrine—Abdominal pain—Ezetimibe—atherosclerosis	0.000701	0.00302	CcSEcCtD
Amsacrine—Body temperature increased—Ezetimibe—atherosclerosis	0.000701	0.00302	CcSEcCtD
Amsacrine—Paraesthesia—Niacin—atherosclerosis	0.000697	0.00301	CcSEcCtD
Amsacrine—Feeling abnormal—Simvastatin—atherosclerosis	0.000697	0.00301	CcSEcCtD
Amsacrine—Dyspnoea—Niacin—atherosclerosis	0.000692	0.00299	CcSEcCtD
Amsacrine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000691	0.00298	CcSEcCtD
Amsacrine—Paraesthesia—Pravastatin—atherosclerosis	0.000686	0.00296	CcSEcCtD
Amsacrine—Dyspnoea—Pravastatin—atherosclerosis	0.000681	0.00294	CcSEcCtD
Amsacrine—Decreased appetite—Niacin—atherosclerosis	0.000675	0.00291	CcSEcCtD
Amsacrine—Rash—Rosuvastatin—atherosclerosis	0.000672	0.0029	CcSEcCtD
Amsacrine—Dermatitis—Rosuvastatin—atherosclerosis	0.000672	0.0029	CcSEcCtD
Amsacrine—Urticaria—Simvastatin—atherosclerosis	0.000672	0.0029	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00067	0.00289	CcSEcCtD
Amsacrine—Abdominal pain—Simvastatin—atherosclerosis	0.000668	0.00288	CcSEcCtD
Amsacrine—Body temperature increased—Simvastatin—atherosclerosis	0.000668	0.00288	CcSEcCtD
Amsacrine—Headache—Rosuvastatin—atherosclerosis	0.000668	0.00288	CcSEcCtD
Amsacrine—Hypersensitivity—Lovastatin—atherosclerosis	0.000666	0.00287	CcSEcCtD
Amsacrine—Decreased appetite—Pravastatin—atherosclerosis	0.000664	0.00287	CcSEcCtD
Amsacrine—Pain—Niacin—atherosclerosis	0.000664	0.00286	CcSEcCtD
Amsacrine—Fatigue—Pravastatin—atherosclerosis	0.000659	0.00284	CcSEcCtD
Amsacrine—Pain—Pravastatin—atherosclerosis	0.000654	0.00282	CcSEcCtD
Amsacrine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000653	0.00282	CcSEcCtD
Amsacrine—Asthenia—Lovastatin—atherosclerosis	0.000649	0.0028	CcSEcCtD
Amsacrine—Asthenia—Ezetimibe—atherosclerosis	0.000636	0.00274	CcSEcCtD
Amsacrine—Gastrointestinal pain—Niacin—atherosclerosis	0.000635	0.00274	CcSEcCtD
Amsacrine—Nausea—Rosuvastatin—atherosclerosis	0.000634	0.00273	CcSEcCtD
Amsacrine—Feeling abnormal—Pravastatin—atherosclerosis	0.00063	0.00272	CcSEcCtD
Amsacrine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000625	0.0027	CcSEcCtD
Amsacrine—Hypersensitivity—Simvastatin—atherosclerosis	0.000623	0.00269	CcSEcCtD
Amsacrine—Diarrhoea—Lovastatin—atherosclerosis	0.000618	0.00267	CcSEcCtD
Amsacrine—Urticaria—Niacin—atherosclerosis	0.000617	0.00266	CcSEcCtD
Amsacrine—Body temperature increased—Niacin—atherosclerosis	0.000614	0.00265	CcSEcCtD
Amsacrine—Abdominal pain—Niacin—atherosclerosis	0.000614	0.00265	CcSEcCtD
Amsacrine—Urticaria—Pravastatin—atherosclerosis	0.000607	0.00262	CcSEcCtD
Amsacrine—Asthenia—Simvastatin—atherosclerosis	0.000607	0.00262	CcSEcCtD
Amsacrine—Diarrhoea—Ezetimibe—atherosclerosis	0.000607	0.00262	CcSEcCtD
Amsacrine—Abdominal pain—Pravastatin—atherosclerosis	0.000604	0.00261	CcSEcCtD
Amsacrine—Body temperature increased—Pravastatin—atherosclerosis	0.000604	0.00261	CcSEcCtD
Amsacrine—Dizziness—Lovastatin—atherosclerosis	0.000598	0.00258	CcSEcCtD
Amsacrine—Dizziness—Ezetimibe—atherosclerosis	0.000586	0.00253	CcSEcCtD
Amsacrine—Diarrhoea—Simvastatin—atherosclerosis	0.000578	0.0025	CcSEcCtD
Amsacrine—Vomiting—Lovastatin—atherosclerosis	0.000575	0.00248	CcSEcCtD
Amsacrine—Hypersensitivity—Niacin—atherosclerosis	0.000572	0.00247	CcSEcCtD
Amsacrine—Rash—Lovastatin—atherosclerosis	0.00057	0.00246	CcSEcCtD
Amsacrine—Dermatitis—Lovastatin—atherosclerosis	0.000569	0.00246	CcSEcCtD
Amsacrine—Headache—Lovastatin—atherosclerosis	0.000566	0.00244	CcSEcCtD
Amsacrine—Vomiting—Ezetimibe—atherosclerosis	0.000564	0.00243	CcSEcCtD
Amsacrine—Hypersensitivity—Pravastatin—atherosclerosis	0.000563	0.00243	CcSEcCtD
Amsacrine—Dizziness—Simvastatin—atherosclerosis	0.000559	0.00241	CcSEcCtD
Amsacrine—Rash—Ezetimibe—atherosclerosis	0.000559	0.00241	CcSEcCtD
Amsacrine—Dermatitis—Ezetimibe—atherosclerosis	0.000558	0.00241	CcSEcCtD
Amsacrine—Asthenia—Niacin—atherosclerosis	0.000557	0.0024	CcSEcCtD
Amsacrine—Headache—Ezetimibe—atherosclerosis	0.000555	0.0024	CcSEcCtD
Amsacrine—Asthenia—Pravastatin—atherosclerosis	0.000548	0.00237	CcSEcCtD
Amsacrine—Vomiting—Simvastatin—atherosclerosis	0.000538	0.00232	CcSEcCtD
Amsacrine—Nausea—Lovastatin—atherosclerosis	0.000537	0.00232	CcSEcCtD
Amsacrine—Rash—Simvastatin—atherosclerosis	0.000533	0.0023	CcSEcCtD
Amsacrine—Dermatitis—Simvastatin—atherosclerosis	0.000533	0.0023	CcSEcCtD
Amsacrine—Diarrhoea—Niacin—atherosclerosis	0.000531	0.00229	CcSEcCtD
Amsacrine—Headache—Simvastatin—atherosclerosis	0.00053	0.00228	CcSEcCtD
Amsacrine—Nausea—Ezetimibe—atherosclerosis	0.000527	0.00227	CcSEcCtD
Amsacrine—Diarrhoea—Pravastatin—atherosclerosis	0.000523	0.00226	CcSEcCtD
Amsacrine—Dizziness—Niacin—atherosclerosis	0.000513	0.00221	CcSEcCtD
Amsacrine—Dizziness—Pravastatin—atherosclerosis	0.000505	0.00218	CcSEcCtD
Amsacrine—Nausea—Simvastatin—atherosclerosis	0.000502	0.00217	CcSEcCtD
Amsacrine—Vomiting—Niacin—atherosclerosis	0.000494	0.00213	CcSEcCtD
Amsacrine—Rash—Niacin—atherosclerosis	0.000489	0.00211	CcSEcCtD
Amsacrine—Dermatitis—Niacin—atherosclerosis	0.000489	0.00211	CcSEcCtD
Amsacrine—Headache—Niacin—atherosclerosis	0.000486	0.0021	CcSEcCtD
Amsacrine—Vomiting—Pravastatin—atherosclerosis	0.000486	0.0021	CcSEcCtD
Amsacrine—Rash—Pravastatin—atherosclerosis	0.000482	0.00208	CcSEcCtD
Amsacrine—Dermatitis—Pravastatin—atherosclerosis	0.000481	0.00208	CcSEcCtD
Amsacrine—Headache—Pravastatin—atherosclerosis	0.000479	0.00207	CcSEcCtD
Amsacrine—Nausea—Niacin—atherosclerosis	0.000461	0.00199	CcSEcCtD
Amsacrine—Nausea—Pravastatin—atherosclerosis	0.000454	0.00196	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000281	0.00198	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—atherosclerosis	0.000279	0.00197	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP7A1—atherosclerosis	0.000276	0.00195	CbGpPWpGaD
Amsacrine—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000274	0.00193	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—SIRT1—atherosclerosis	0.000269	0.0019	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CD36—atherosclerosis	0.000268	0.00189	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.000264	0.00186	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000263	0.00186	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP27A1—atherosclerosis	0.000255	0.0018	CbGpPWpGaD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000252	0.00178	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000251	0.00177	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.00025	0.00176	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PPARA—atherosclerosis	0.000249	0.00175	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PRKCG—atherosclerosis	0.000246	0.00174	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000245	0.00173	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PLA2G2A—atherosclerosis	0.000242	0.00171	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOA2—atherosclerosis	0.000242	0.00171	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALOX5AP—atherosclerosis	0.000242	0.00171	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALOX15—atherosclerosis	0.000242	0.00171	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ABCG5—atherosclerosis	0.000239	0.00169	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000239	0.00169	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—LEP—atherosclerosis	0.000236	0.00167	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CD40—atherosclerosis	0.000234	0.00165	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LPA—atherosclerosis	0.000231	0.00163	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PPARA—atherosclerosis	0.000224	0.00158	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—BGN—atherosclerosis	0.000224	0.00158	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000222	0.00157	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000222	0.00157	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOA5—atherosclerosis	0.000221	0.00156	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP7A1—atherosclerosis	0.00022	0.00155	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000217	0.00153	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000215	0.00152	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	0.000214	0.00151	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PLA2G1B—atherosclerosis	0.000213	0.0015	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—LEP—atherosclerosis	0.000212	0.0015	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000211	0.00149	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000211	0.00149	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.00021	0.00148	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.00021	0.00148	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000209	0.00147	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000208	0.00147	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALOX5—atherosclerosis	0.000206	0.00145	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PPARG—atherosclerosis	0.000206	0.00145	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP27A1—atherosclerosis	0.000203	0.00143	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—INS—atherosclerosis	0.000202	0.00142	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP27A1—atherosclerosis	0.0002	0.00141	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—AKT1—atherosclerosis	0.000198	0.0014	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—NOS2—atherosclerosis	0.000198	0.0014	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.00019	0.00134	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP2—atherosclerosis	0.000189	0.00133	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PPARG—atherosclerosis	0.000185	0.00131	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NAMPT—atherosclerosis	0.000185	0.0013	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000184	0.0013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000184	0.0013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LIPC—atherosclerosis	0.000184	0.00129	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—PRKCG—atherosclerosis	0.000183	0.00129	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000183	0.00129	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOC3—atherosclerosis	0.000182	0.00129	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LDLR—atherosclerosis	0.000181	0.00128	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	0.000179	0.00127	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL10—atherosclerosis	0.000179	0.00127	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CETP—atherosclerosis	0.000177	0.00125	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.000171	0.0012	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SCARB1—atherosclerosis	0.00017	0.0012	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000167	0.00118	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FASLG—atherosclerosis	0.000167	0.00118	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000167	0.00118	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000165	0.00116	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.00016	0.00113	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HMGCR—atherosclerosis	0.00016	0.00113	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	0.000159	0.00112	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000152	0.00107	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000151	0.00107	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000149	0.00105	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000144	0.00102	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ABCA1—atherosclerosis	0.000143	0.00101	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP9—atherosclerosis	0.000142	0.001	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NFKB1—atherosclerosis	0.00014	0.00099	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000136	0.000957	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	0.000134	0.000944	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000132	0.000929	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000129	0.000913	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—atherosclerosis	0.000127	0.000899	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—STAT3—atherosclerosis	0.000126	0.00089	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—MAPK8—atherosclerosis	0.000124	0.000876	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000124	0.000875	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HMOX1—atherosclerosis	0.000122	0.000864	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAPK3—atherosclerosis	0.000121	0.00085	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000119	0.000843	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000119	0.000839	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOB—atherosclerosis	0.000117	0.000827	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TGFB1—atherosclerosis	0.000117	0.000825	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000116	0.00082	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000115	0.000809	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTM1—atherosclerosis	0.000114	0.000805	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000113	0.000797	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—LPL—atherosclerosis	0.000112	0.00079	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.00011	0.000773	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GPX1—atherosclerosis	0.000109	0.000771	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—atherosclerosis	0.000109	0.00077	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CD36—atherosclerosis	0.000106	0.000751	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IFNG—atherosclerosis	0.000106	0.000745	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000102	0.000722	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MTHFR—atherosclerosis	0.000101	0.000711	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARA—atherosclerosis	9.89e-05	0.000698	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	9.81e-05	0.000692	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AGT—atherosclerosis	9.58e-05	0.000676	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL1B—atherosclerosis	9.41e-05	0.000664	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	9.39e-05	0.000663	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOE—atherosclerosis	9.39e-05	0.000662	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—atherosclerosis	9.38e-05	0.000662	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CAV1—atherosclerosis	9.3e-05	0.000656	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOA1—atherosclerosis	9.28e-05	0.000655	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	9.24e-05	0.000652	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	9.2e-05	0.000649	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	9.08e-05	0.00064	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	8.95e-05	0.000632	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—atherosclerosis	8.81e-05	0.000622	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	8.52e-05	0.000601	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—atherosclerosis	8.47e-05	0.000598	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	8.23e-05	0.000581	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARG—atherosclerosis	8.18e-05	0.000577	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT1—atherosclerosis	8.13e-05	0.000573	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—INS—atherosclerosis	8.02e-05	0.000566	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	7.97e-05	0.000562	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—atherosclerosis	7.93e-05	0.00056	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.66e-05	0.00054	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.62e-05	0.000538	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	7.37e-05	0.00052	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—atherosclerosis	7.35e-05	0.000519	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	7.31e-05	0.000516	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NOS3—atherosclerosis	7.03e-05	0.000496	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	6.96e-05	0.000491	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—atherosclerosis	6.83e-05	0.000482	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LDLRAP1—atherosclerosis	6.83e-05	0.000482	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	6.43e-05	0.000454	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—atherosclerosis	6.43e-05	0.000454	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLTP—atherosclerosis	6.42e-05	0.000453	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLTP—atherosclerosis	6.05e-05	0.000427	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.02e-05	0.000425	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	5.87e-05	0.000414	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG8—atherosclerosis	5.57e-05	0.000393	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LTA4H—atherosclerosis	5.57e-05	0.000393	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	5.47e-05	0.000386	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	5.46e-05	0.000385	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LTA4H—atherosclerosis	5.25e-05	0.00037	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG8—atherosclerosis	5.25e-05	0.00037	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	4.99e-05	0.000352	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK3—atherosclerosis	4.89e-05	0.000345	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.81e-05	0.000339	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG1—atherosclerosis	4.4e-05	0.00031	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	4.33e-05	0.000306	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.26e-05	0.000301	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG1—atherosclerosis	4.15e-05	0.000293	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LCAT—atherosclerosis	4.14e-05	0.000292	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FABP4—atherosclerosis	4.14e-05	0.000292	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.09e-05	0.000289	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOA4—atherosclerosis	4.06e-05	0.000287	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP7A1—atherosclerosis	3.99e-05	0.000281	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.93e-05	0.000277	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LCAT—atherosclerosis	3.9e-05	0.000275	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FABP4—atherosclerosis	3.9e-05	0.000275	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOA4—atherosclerosis	3.83e-05	0.00027	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.77e-05	0.000266	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	3.76e-05	0.000265	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.72e-05	0.000262	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP27A1—atherosclerosis	3.69e-05	0.00026	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.61e-05	0.000255	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.61e-05	0.000255	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOA2—atherosclerosis	3.5e-05	0.000247	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.5e-05	0.000247	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.5e-05	0.000247	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALOX15—atherosclerosis	3.5e-05	0.000247	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	3.47e-05	0.000245	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG5—atherosclerosis	3.45e-05	0.000244	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.37e-05	0.000238	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LPA—atherosclerosis	3.33e-05	0.000235	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOA2—atherosclerosis	3.29e-05	0.000232	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALOX15—atherosclerosis	3.29e-05	0.000232	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	3.29e-05	0.000232	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	3.29e-05	0.000232	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.25e-05	0.00023	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—atherosclerosis	3.23e-05	0.000228	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BGN—atherosclerosis	3.23e-05	0.000228	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOA5—atherosclerosis	3.2e-05	0.000226	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LPA—atherosclerosis	3.14e-05	0.000222	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.08e-05	0.000217	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.05e-05	0.000215	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BGN—atherosclerosis	3.04e-05	0.000215	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOA5—atherosclerosis	3.01e-05	0.000213	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALOX5—atherosclerosis	2.97e-05	0.00021	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.9e-05	0.000205	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.86e-05	0.000202	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.8e-05	0.000198	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAMPT—atherosclerosis	2.67e-05	0.000188	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LIPC—atherosclerosis	2.65e-05	0.000187	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOC3—atherosclerosis	2.63e-05	0.000186	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LDLR—atherosclerosis	2.62e-05	0.000185	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CETP—atherosclerosis	2.56e-05	0.00018	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.51e-05	0.000177	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.51e-05	0.000177	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LIPC—atherosclerosis	2.5e-05	0.000176	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOC3—atherosclerosis	2.48e-05	0.000175	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LDLR—atherosclerosis	2.47e-05	0.000174	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SCARB1—atherosclerosis	2.45e-05	0.000173	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CETP—atherosclerosis	2.41e-05	0.00017	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMGCR—atherosclerosis	2.31e-05	0.000163	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.31e-05	0.000163	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.27e-05	0.00016	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.18e-05	0.000154	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCA1—atherosclerosis	2.06e-05	0.000145	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.94e-05	0.000137	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMOX1—atherosclerosis	1.77e-05	0.000125	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOB—atherosclerosis	1.69e-05	0.000119	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.67e-05	0.000118	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—atherosclerosis	1.65e-05	0.000116	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LPL—atherosclerosis	1.62e-05	0.000114	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOB—atherosclerosis	1.6e-05	0.000113	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX1—atherosclerosis	1.58e-05	0.000111	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.55e-05	0.00011	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CD36—atherosclerosis	1.54e-05	0.000108	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LPL—atherosclerosis	1.52e-05	0.000107	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX1—atherosclerosis	1.49e-05	0.000105	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—atherosclerosis	1.46e-05	0.000103	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CD36—atherosclerosis	1.45e-05	0.000102	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARA—atherosclerosis	1.43e-05	0.000101	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AGT—atherosclerosis	1.38e-05	9.76e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.37e-05	9.68e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOE—atherosclerosis	1.36e-05	9.56e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARA—atherosclerosis	1.35e-05	9.49e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAV1—atherosclerosis	1.34e-05	9.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOA1—atherosclerosis	1.34e-05	9.45e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AGT—atherosclerosis	1.3e-05	9.2e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOE—atherosclerosis	1.28e-05	9.01e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAV1—atherosclerosis	1.27e-05	8.93e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOA1—atherosclerosis	1.26e-05	8.91e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.22e-05	8.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—atherosclerosis	1.18e-05	8.33e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—INS—atherosclerosis	1.16e-05	8.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.15e-05	8.13e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.11e-05	7.85e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—INS—atherosclerosis	1.09e-05	7.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—atherosclerosis	1.06e-05	7.49e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NOS3—atherosclerosis	1.02e-05	7.16e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—atherosclerosis	1e-05	7.06e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NOS3—atherosclerosis	9.57e-06	6.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—atherosclerosis	9.29e-06	6.55e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—atherosclerosis	8.75e-06	6.17e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—atherosclerosis	4.67e-06	3.29e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—atherosclerosis	4.4e-06	3.1e-05	CbGpPWpGaD
